[Edaily Reporter Park Jung-Soo ] Jayjun Cosmetic(025620)is surging for the second consecutive day following a large-scale long-term supply contract for a product. According to MP Doctor on the 24th, as of 9:09 a.m., CHA AI Healthkare is trading at 9,120 won, up 21.60% (1,620 won) from the previous trading day. The stock hit its daily price limit the previous day. After the market closed on the 22nd, CHA AI Healthkare announced that it had signed a long-term product supply contract worth 52.6 billion won with Nissho Medical. The contract value (5 billion won in the first year, 8.5 billion won in the second year, 12.5 billion won in the third year, 13 billion won in the fourth year, and 13.6 billion won in the fifth year) amounts to 720.05% of last year’s consolidated revenue. The contract period runs through June 22, 2031.
This week (November 16–20), startups in various fields—including robotics, image analysis, and business platforms—secured investments from venture capital (VC) firms and accelerators (ACs). In particu…
Celltrion(068270)Forecasts indicate that Celltrion will continue its steep earnings growth as it expands its direct sales performance in the U.S. biosimilar market. Expectations for a revaluation of t…
South Korean pharmaceutical and biotechnology stocks posted mixed results on November 19, driven by clinical trial developments and expectations regarding their inclusion in major stock indices. Penet…